Globus Medical Debt to Equity Ratio 2010-2018 | GMED
Current and historical debt to equity ratio values for Globus Medical (GMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Globus Medical debt/equity for the three months ending September 30, 2018 was 0.00.
| Globus Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.00B | $1.14B | 0.00 |
| 2018-06-30 | $0.00B | $1.10B | 0.00 |
| 2018-03-31 | $0.00B | $1.03B | 0.00 |
| 2017-12-31 | $0.00B | $0.97B | 0.00 |
| 2017-09-30 | $0.00B | $0.94B | 0.00 |
| 2017-06-30 | $0.00B | $0.91B | 0.00 |
| 2017-03-31 | $0.00B | $0.87B | 0.00 |
| 2016-12-31 | $0.00B | $0.83B | 0.00 |
| 2016-09-30 | $0.00B | $0.81B | 0.00 |
| 2016-06-30 | $0.00B | $0.78B | 0.00 |
| 2016-03-31 | $0.00B | $0.75B | 0.00 |
| 2015-12-31 | $0.00B | $0.72B | 0.00 |
| 2015-09-30 | $0.00B | $0.67B | 0.00 |
| 2015-06-30 | $0.00B | $0.64B | 0.00 |
| 2015-03-31 | $0.00B | $0.61B | 0.00 |
| 2014-12-31 | $0.00B | $0.59B | 0.00 |
| 2014-09-30 | $0.00B | $0.55B | 0.00 |
| 2014-06-30 | $0.00B | $0.53B | 0.00 |
| 2014-03-31 | $0.00B | $0.50B | 0.00 |
| 2013-12-31 | $0.00B | $0.47B | 0.00 |
| 2013-09-30 | $0.00B | $0.45B | 0.00 |
| 2013-06-30 | $0.00B | $0.42B | 0.00 |
| 2013-03-31 | $0.00B | $0.41B | 0.00 |
| 2012-12-31 | $0.00B | $0.39B | 0.00 |
| 2012-09-30 | $0.00B | $0.36B | 0.00 |
| 2012-06-30 | $0.00B | $0.32B | 0.00 |
| 2012-03-31 | $0.00B | $0.30B | 0.00 |
| 2011-12-31 | $0.00B | $0.28B | 0.00 |
| 2011-09-30 | $0.00B | $0.00B | 0.00 |
| 2011-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-03-31 | $0.00B | $0.00B | 0.00 |
| 2010-12-31 | $0.00B | $0.23B | 0.00 |
| 2009-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.509B | $0.636B |
| Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.952B | 22.13 |
| Intuitive Surgical (ISRG) | United States | $56.151B | 55.25 |
| Edwards Lifesciences (EW) | United States | $32.865B | 35.17 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.890B | 14.80 |
| IDEXX Laboratories (IDXX) | United States | $16.385B | 46.80 |
| ABIOMED (ABMD) | United States | $14.301B | 102.76 |
| Hologic (HOLX) | United States | $12.141B | 18.74 |
| Teleflex (TFX) | United States | $11.801B | 26.79 |
| Varian Medical Systems (VAR) | United States | $10.826B | 26.94 |
| DexCom (DXCM) | United States | $10.787B | 0.00 |
| STERIS (STE) | United Kingdom | $9.628B | 25.55 |
| Masimo (MASI) | United States | $5.580B | 36.19 |
| LivaNova (LIVN) | United Kingdom | $4.617B | 29.64 |
| Penumbra (PEN) | United States | $4.545B | 274.42 |
| Integra LifeSciences Holdings (IART) | United States | $4.256B | 20.73 |
| Cantel Medical (CMD) | United States | $3.351B | 33.05 |
| Wright Medical Group (WMGI) | Netherlands | $3.313B | 0.00 |
| Inogen (INGN) | United States | $2.966B | 64.02 |
| Integer Holdings (ITGR) | United States | $2.712B | 22.70 |
| Glaukos (GKOS) | United States | $2.247B | 0.00 |
| Halyard Health (AVNS) | United States | $2.186B | 19.70 |
| Tandem Diabetes Care (TNDM) | United States | $1.921B | 0.00 |
| OPKO Health (OPK) | United States | $1.836B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.532B | 0.00 |
| Luminex (LMNX) | United States | $1.267B | 45.84 |
| Nevro (NVRO) | United States | $1.250B | 0.00 |
| AxoGen (AXGN) | United States | $1.137B | 0.00 |
| Natus Medical (BABY) | United States | $1.133B | 23.79 |
| Pacific Biosciences Of California (PACB) | United States | $1.121B | 0.00 |
| Orthofix (OFIX) | United States | $1.066B | 30.78 |
| CryoLife (CRY) | United States | $1.057B | 92.19 |
| Tactile Systems Technology (TCMD) | United States | $0.988B | 157.38 |
| Intersect ENT (XENT) | United States | $0.940B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.815B | 48.19 |
| AngioDynamics (ANGO) | United States | $0.771B | 26.99 |
| Accelerate Diagnostics (AXDX) | United States | $0.767B | 0.00 |
| ViewRay (VRAY) | United States | $0.603B | 0.00 |
| SI-BONE INC (SIBN) | United States | $0.494B | 0.00 |
| Sientra (SIEN) | United States | $0.493B | 0.00 |
| Veracyte (VCYT) | United States | $0.483B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.395B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.361B | 0.00 |
| Neuronetics (STIM) | United States | $0.346B | 0.00 |
| Accuray (ARAY) | United States | $0.334B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.319B | 0.00 |
| Nuvectra (NVTR) | United States | $0.316B | 0.00 |
| Fluidigm (FLDM) | United States | $0.309B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.281B | 0.00 |
| IRadimed (IRMD) | United States | $0.278B | 72.57 |
| RTI Surgical (RTIX) | United States | $0.242B | 38.20 |
| Helius Medical Technologies (HSDT) | United States | $0.234B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.219B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.184B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.115B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.113B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.111B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.089B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.088B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.077B | 0.00 |
| EDAP TMS (EDAP) | France | $0.075B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.065B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.045B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.043B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.041B | 0.00 |
| Vermillion (VRML) | United States | $0.039B | 0.00 |
| ConforMIS (CFMS) | United States | $0.032B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.028B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.025B | 0.00 |
| Dynatronics (DYNT) | United States | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.020B | 0.00 |
| Neovasc (NVCN) | Canada | $0.018B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Presbia (LENS) | Ireland | $0.011B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.001B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
